1. Evaluation of poly (lactic-co-glycolic acid) nanoparticles to improve the therapeutic efficacy of paclitaxel in breast cancer

Laura Cabeza , Mazen M. El-Hammadi , Raul Ortiz , Maria D. Cayero-Otero, Julia Jiménez-López , Gloria Perazzoli , Lucia Martin-Banderas , Jose M. Baeyens , Consolación Melguizo* , Jose Prados

BioImpacts. 2022;12(6): 515-531. doi: 10.34172/bi.2022.23433

PMCID: PMC9809141 PMID: 36644541 Scopus ID: 85140308481

Article

PDF

Suppl 1

Full Text

XML

Cited By:

These results suggest that our PTX-PLGA NPs could be a suitable strategy for breast cancer therapy, improving antitumor drug efficiency and reducing systemic toxicity without altering its mechanism of action.

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons